Source: Proceedings of the American Association for Cancer Research. Conference titles: Annual Meeting American Association for Cancer Research. Unidade: FM
Subjects: MELANOMA, SINERGISMO DE DROGAS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDRADE, Luciana N. S. et al. Synergism between dacarbazine and antagonist of the bradykinin receptor subtype I impaired melanoma associated angiogenesis. Proceedings of the American Association for Cancer Research. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 06 nov. 2024. , 2006APA
Andrade, L. N. S., Pinheiro, M. C., Nonogaki, S., Nantel, F., Battistini, B., Sirois, P., & Chammas, R. (2006). Synergism between dacarbazine and antagonist of the bradykinin receptor subtype I impaired melanoma associated angiogenesis. Proceedings of the American Association for Cancer Research. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.NLM
Andrade LNS, Pinheiro MC, Nonogaki S, Nantel F, Battistini B, Sirois P, Chammas R. Synergism between dacarbazine and antagonist of the bradykinin receptor subtype I impaired melanoma associated angiogenesis. Proceedings of the American Association for Cancer Research. 2006 ; 47 412. res. 1748.[citado 2024 nov. 06 ]Vancouver
Andrade LNS, Pinheiro MC, Nonogaki S, Nantel F, Battistini B, Sirois P, Chammas R. Synergism between dacarbazine and antagonist of the bradykinin receptor subtype I impaired melanoma associated angiogenesis. Proceedings of the American Association for Cancer Research. 2006 ; 47 412. res. 1748.[citado 2024 nov. 06 ]
